CDH17 and neoplasm: One theory states that decreased levels of CDH17 immunohistochemical expression stimulate tumor cell invasion by increasing tumor cell adherence and possible migration (by changing galectin-3 immunohistochemical expression), as well as by degrading the extracellular matrix (ECM) (through MMP-2 and MMP-9 activation) [20,22].